Legal & General Group Plc - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 66 filers reported holding TG THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,001,493
+32.2%
168,718
+13.0%
0.00%0.0%
Q1 2024$2,270,184
-9.6%
149,256
+1.5%
0.00%0.0%
Q4 2023$2,512,434
+121.4%
147,098
+8.4%
0.00%
Q3 2023$1,134,570
-65.8%
135,714
+1.7%
0.00%
-100.0%
Q2 2023$3,313,631
+77.5%
133,399
+7.5%
0.00%0.0%
Q1 2023$1,867,020
+38.4%
124,137
+8.8%
0.00%0.0%
Q4 2022$1,349,235
+83.3%
114,052
-8.3%
0.00%
Q3 2022$736,000
+22.9%
124,356
-11.8%
0.00%
Q2 2022$599,000
-42.5%
140,981
+28.8%
0.00%
Q1 2022$1,041,000
-49.9%
109,452
+0.1%
0.00%
-100.0%
Q4 2021$2,078,000
-42.7%
109,371
+0.3%
0.00%0.0%
Q3 2021$3,629,000
+17.9%
109,043
+37.5%
0.00%0.0%
Q2 2021$3,077,000
-17.7%
79,304
+2.2%
0.00%0.0%
Q1 2021$3,740,000
-4.1%
77,593
+3.5%
0.00%
-50.0%
Q4 2020$3,899,000
+137.0%
74,948
+21.9%
0.00%
+100.0%
Q3 2020$1,645,000
+260.0%
61,458
+161.8%
0.00%
Q2 2020$457,000
+114.6%
23,475
+8.3%
0.00%
Q1 2020$213,000
-24.2%
21,675
-14.5%
0.00%
Q4 2019$281,000
+136.1%
25,359
+19.9%
0.00%
Q3 2019$119,000
-22.2%
21,156
+19.6%
0.00%
Q2 2019$153,000
+86.6%
17,682
+73.6%
0.00%
Q1 2019$82,000
+95.2%
10,1850.0%0.00%
Q4 2018$42,000
-26.3%
10,1850.0%0.00%
Q3 2018$57,000
-53.3%
10,185
+9.6%
0.00%
Q2 2018$122,000
-10.3%
9,291
-2.9%
0.00%
Q1 2018$136,000
+19.3%
9,566
-29.4%
0.00%
Q4 2017$114,000
-23.0%
13,559
+8.5%
0.00%
Q3 2017$148,000
+29.8%
12,500
+11.0%
0.00%
Q2 2017$114,000
+0.9%
11,264
+14.9%
0.00%
Q1 2017$113,000
+156.8%
9,801
+4.1%
0.00%
Q4 2016$44,000
-8.3%
9,417
+50.0%
0.00%
Q3 2016$48,000
+11.6%
6,278
-12.6%
0.00%
Q2 2016$43,000
-33.8%
7,1850.0%0.00%
Q1 2016$65,000
+18.2%
7,185
+54.4%
0.00%
Q4 2015$55,000
+19.6%
4,6530.0%0.00%
Q3 2015$46,000
-38.7%
4,6530.0%0.00%
Q2 2015$75,0000.0%4,6530.0%0.00%
Q1 2015$75,000
-1.3%
4,6530.0%0.00%
Q4 2014$76,000
+52.0%
4,6530.0%0.00%
Q3 2014$50,0004,6530.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Jetstream Capital LLC 200,000$7,758,0005.97%
Lion Point Capital, LP 609,128$23,628,0004.08%
RA Capital Management 3,342,743$129,665,0002.08%
Ghost Tree Capital, LLC 180,000$6,982,0001.92%
Nicholas Investment Partners, LP 660,964$25,639,0001.61%
ARDSLEY ADVISORY PARTNERS LP 350,000$13,577,0001.60%
SECTORAL ASSET MANAGEMENT INC 414,949$16,096,0001.30%
Spotlight Asset Group, Inc. 75,000$2,909,0001.12%
ACT CAPITAL MANAGEMENT, LLC 55,000$2,134,0001.10%
Pier Capital, LLC 280,486$10,880,0001.09%
View complete list of TG THERAPEUTICS INC shareholders